ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,052Medicare Part D Prescriptions Filled, Including Refills

Rank: 171 out of 676

$654K Total Retail Price of All Prescriptions

Rank: 146 out of 676

378 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 378 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

25% of this provider’s 378 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 9,793 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
AMLODIPINE BESYLATE 533 455 1 3
LISINOPRIL 501 417 2 5
HYDROCODONE-ACETAMINOPHEN 480 260 S3 3 1
SIMVASTATIN 451 385 4 6
FUROSEMIDE 346 296 5 4
OMEPRAZOLE 253 189 6 2
POTASSIUM CHLORIDE 253 232 6 9
NAMENDA 252 244 8 35
LEVOTHYROXINE SODIUM 241 205 9 7
BYSTOLIC 226 214 10 96
MELOXICAM 207 158 11 13
GABAPENTIN 203 149 12 10
CITALOPRAM HBR 193 167 13 17
DONEPEZIL HCL 168 158 14 24
CRESTOR 155 117 15 29
ATORVASTATIN CALCIUM 154 117 16 20
ALENDRONATE SODIUM 150 138 17 61
METOPROLOL SUCCINATE 127 125 18 14
CARVEDILOL 126 104 19 15
WARFARIN SODIUM 115 114 20 18
POLYETHYLENE GLYCOL 3350 114 104 21 56
GLIMEPIRIDE 113 91 22 30
QUETIAPINE FUMARATE 110 110 23 72
PRAVASTATIN SODIUM 109 109 24 11
LOVASTATIN 107 85 25 33
METFORMIN HCL ER 106 80 26 63
LISINOPRIL-HYDROCHLOROTHIAZIDE 105 65 27 16
FENTANYL 101 49 S2 28 93
AMITRIPTYLINE HCL 100 72 R 29 46
HYDROCHLOROTHIAZIDE 99 78 30 12
JANUVIA 98 91 31 78
ESCITALOPRAM OXALATE 96 84 32 73
FAMOTIDINE 95 95 33 64
CLOPIDOGREL 94 92 34 28
DIOVAN HCT 91 86 35 41
METFORMIN HCL 89 54 36 8
CLONIDINE HCL 86 56 37 32
METOCLOPRAMIDE HCL 84 71 38 107
DIOVAN 84 81 38 37
PANTOPRAZOLE SODIUM 84 43 38 42
GLYBURIDE-METFORMIN HCL 82 58 R 41 76
CYCLOBENZAPRINE HCL 79 32 R 42 50
AZITHROMYCIN 76 58 43 39
SPIRONOLACTONE 75 55 44 62
TRAZODONE HCL 73 51 45 36
SERTRALINE HCL 72 62 46 26
CYMBALTA 72 30 46 47
AGGRENOX 71 42 48 147
TAMSULOSIN HCL 70 58 49 38
LANTUS 69 53 50 55
ZETIA 66 42 51 89
FENOFIBRATE 66 52 51 90
RANITIDINE HCL 64 59 53 27
NITROFURANTOIN 62 62 54 206
PLAVIX 62 60 54 40
TRAMADOL HCL 61 49 56 19
TRICOR 59 40 57 126
ISOSORBIDE MONONITRATE ER 57 41 58 54
LIPITOR 57 52 58 94
PRAMIPEXOLE DIHYDROCHLORIDE 54 42 60 204
CELEBREX 54 47 60 108
FLUOXETINE HCL 53 39 62 70
AMLODIPINE BESYLATE-BENAZEPRIL 51 45 63 44
BUSPIRONE HCL 50 36 64 113
DIGOXIN 50 50 64 52
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 12, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.